Hendrik Peter Scholl MD
Retinal Disease
Professor of Ophthalmology, Johns Hopkins University School of Medicine; Director, Retinal Degeneration Clinic, Dr. Frieda Derdeyn Bambas Professor of Ophthalmology, Director, Visual Neurophysiology Service, Co-director, Johns Hopkins Center for Stem Cells and Ophthalmic Regenerative Medicine (STORM)
Join to View Full Profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-5000
Dr. Scholl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Ophthalmology, 1996 - 1997- Rhode Island Hospital/Brown University HealthPost-Doctoral Fellowship, Clinical Cardiac Electrophysiology, 1996 - 1997
Eberhard-Karls UniviversityMD, MA, 1989 - 1997- Eberhard-Karls UniviversityMD, MA, Medicine, Philosophy, 1989 - 1997
- Eberhard-Karls UniviversityMD, MA, Medicine, Philosophy, Magna Cum Laude, 1989 - 1997
Certifications & Licensure
MD State Medical License 2010 - 2017
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) Start of enrollment: 2007 Aug 01
- A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies Start of enrollment: 2013 Aug 01
- The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism Start of enrollment: 2014 Nov 01
Publications & Presentations
PubMed
- 1 citations360° LASER VERSUS LOCALIZED RETINOPEXY IN THE SURGICAL MANAGEMENT OF PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT USING PARS PLANA VITRECTOMY.Jonas Stücheli, Christophe Valmaggia, Hendrik P N Scholl, Ivo Guber, Josef Guber
Retina. 2025-10-01 - 1 citationsVariants in the AGBL5 gene are responsible for autosomal recessive Retinitis pigmentosa with hearing loss.Marianthi Karali, Gema García-García, Karolina Kaminska, Alaa AlTalbishi, Francesca Cancellieri
European Journal of Human Genetics. 2025-06-01 - Variants in CFAP410 cause a range of retinal and skeletal phenotypes.Ryan E Schmidt, Amy E Pohodich, David Birch, Kaylie Jones, Byron L Lam
NPJ Genomic Medicine. 2025-04-17
Press Mentions
Earlier Role for Complement C3 Inhibitor in AMD?February 8th, 2022- Reversing Blindness: Award for Cone Optogenetics Gene TherapyApril 29th, 2021
Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt DiseaseJanuary 26th, 2017
Professional Memberships
- Member
- Member
Other Languages
- German
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/hendrik-scholl
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
